As per new report released by RNCOS, entitled “Global Regenerative Medicine Market”
, the worldwide market for regenerative medicine has witnessed a stupendous growth over the past few years. Factors such as aging population and huge R&D investment have led to create a US$ 7.2 Billion worth global regenerative medicine market in 2010. Among the products that may show interests in future, allogeneic adult cells will be an attractive regenerative cell therapy.
Our research report revealed that European countries hold a dominant position in global regenerative medicine market. Owing to key factors, such as active private sector participation and growing demand for cost-effective treatment options, the European market, with a share of 30.6% in the global regenerative medicine industry, reached the mark of US$ 2.2 Billion in 2010. In future, the market is anticipated to exhibit a CAGR growth of 19% during 2011-2014.
The report “Global Regenerative Medicine Market”
covers the regenerative medicine market landscape in developed regions, such as the US and Europe, and emerging markets like India and China. It investigates the key industry characteristics and trends that have a large impact in the market performance. The report also summarizes the patent landscape and entails comprehensive information on the pipeline products of key companies.
The report is an outcome of extensive research and prudent analysis of the global regenerative medicine market that provides a deep insight into the growth of key segments. Future forecasts for the industry in the report calculated on the basis of the sum of economic and judgmental analysis based on past drivers, challenges, and opportunities for expansion. Overall, the report is likely to provide clients with an optimum source of knowledge and statistics on regenerative medicine sector worldwide.
Some of our Related Reports are: